Etretinate - Superior Pharmaceutical-Grade Psoriasis Treatment
ProcurenetShort description
Product: Premium Pharmaceutical-Grade Psoriasis Treatment – Etretinate. Active Ingredient: Synthetic retinoid etretinium. Key Features:
- Formulation: Oral capsules of 10mg etretinoin.
- Utility: Mitigates psoriasis symptoms by controlling skin cell growth and reducing inflammation levels.
- Safety: Not endorsed for use by pregnant or breastfeeding women. Importance of proper contraception during usage period.
- Precautions: Essential to disclose medical history and ongoing medication details prior to usage to prevent potential complications.
Storage: Retain in room temperature settings. Avoid exposure to light, heat and moisture.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Etretinate - Premium Pharmaceutical-Grade Psoriasis Treatment
Etretinate, a premium Pharmaceutical-grade compound, is a recognized mainstay in the realm of psoriasis management. Synthetically manufactured in Hangzhou, it has risen to prominence in the pharmaceutical industry as a valuable treatment option for severe and resistant psoriasis, marking an international footprint spanning North America, Central/South America, Eastern Europe, Western Europe, Australasia, Asia, the Middle East, and Africa. The compound’s role in psoriasis treatment is transformative, capable of putting to halt the excessive growth and keratinisation of skin cells usually associated with the condition.
- CAS Number: 54350-48-0
- Molecular Formula: C25H32O2
- Molecular Weight: 368.5 g/mol
- IUPAC Name: [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (2E)-2-methylbut-2-enoate
- Synonyms: Tegison, Tigason
- Melting Point: 136-140 °C
- Density: 0.909 g/cm³
- Solubility: Practically insoluble in water; however, it is soluble in methylene chloride and ethanol.
This long-acting, oral medication soothes the scaling and redness symptomatic of severe psoriasis by inhibiting pathological cell proliferation and keratinisation.
Therapeutic Uses
Etretinate is broadly used to treat severe and resistant psoriasis, including pustular psoriasis and erythroderma. Its functionality as an antipsoriatic has made it an indispensable therapeutic agent for controlling psoriasis.
Side Effects
Some common side effects associated with Etretinate include skin irritation, rash, and altered lipid levels. It’s essential to note that its use during pregnancy can cause harm to the fetus, necessitating the implementation of apt contraceptive measures during and after the treatment course.
Note: Sample provision for this product is not available currently.
